Tower Research Capital LLC (Trc) Syndax Pharmaceuticals Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 18,190 shares of SNDX stock, worth $209,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,190
Previous 6,509
179.46%
Holding current value
$209,912
Previous $125,000
92.0%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
92.7MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$98.3 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$91.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$68.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$61.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$56.3 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $653M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...